Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 386

1.

Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function.

Nagate Y, Ezoe S, Fujita J, Okuzakis D, Motooka D, Ishibashi T, Ichii M, Tanimura A, Kurashige M, Morii E, Fukushima T, Suehiro Y, Yokota T, Shibayama H, Oritani K, Kanakura Y.

Leukemia. 2020 Mar 20. doi: 10.1038/s41375-020-0788-y. [Epub ahead of print]

PMID:
32203145
2.

Limbic encephalitis with antibodies to N-methyl-D-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation.

Toda J, Maeda T, Akuta K, Kusakabe S, Ueda T, Fujita J, Shibayama H, Oritani K, Takahashi Y, Kanakura Y.

Int J Hematol. 2020 Mar 21. doi: 10.1007/s12185-020-02859-0. [Epub ahead of print]

PMID:
32200528
3.

Reevaluation of platelet function in chronic immune thrombocytopenia: impacts of platelet size, platelet-associated anti-αIIbβ3 antibodies and thrombopoietin receptor agonists.

Nishiura N, Kashiwagi H, Akuta K, Hayashi S, Kato H, Kanakura Y, Tomiyama Y.

Br J Haematol. 2020 Feb 27. doi: 10.1111/bjh.16439. [Epub ahead of print]

PMID:
32106338
4.

Enterococcus: A Predictor of Ravaged Microbiota and Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation.

Kusakabe S, Fukushima K, Yokota T, Hino A, Fujita J, Motooka D, Nakamura S, Shibayama H, Kanakura Y.

Biol Blood Marrow Transplant. 2020 Feb 1. pii: S1083-8791(20)30052-5. doi: 10.1016/j.bbmt.2020.01.019. [Epub ahead of print]

PMID:
32018061
5.

Signal-transducing adaptor protein-2 delays recovery of B lineage lymphocytes during hematopoietic stress.

Ichii M, Oritani K, Toda J, Saito H, Shi H, Shibayama H, Motooka D, Kitai Y, Muromoto R, Kashiwakura JI, Saitoh K, Okuzaki D, Matsuda T, Kanakura Y.

Haematologica. 2020 Jan 23. pii: haematol.2019.225573. doi: 10.3324/haematol.2019.225573. [Epub ahead of print]

6.

Unexpected Complication of R-CHOP Chemotherapy: Rapidly Progressive Bronchiolitis Obliterans Syndrome.

Nozaki K, Ezoe S, Hamaguchi M, Tsutsumi K, Kusakabe S, Morikawa Y, Fujita J, Fukushima K, Maeda T, Shibayama H, Kumanogo A, Kanakura Y.

Eur J Case Rep Intern Med. 2019 Oct 28;6(11):001266. doi: 10.12890/2019_001266. eCollection 2019.

7.

Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan).

Schols S, Nunn MA, Mackie I, Weston-Davies W, Nishimura JI, Kanakura Y, Blijlevens N, Muus P, Langemeijer S.

Br J Haematol. 2020 Jan;188(2):334-337. doi: 10.1111/bjh.16305. Epub 2019 Dec 16. No abstract available.

PMID:
31840801
8.

Endothelial Cell-Selective Adhesion Molecule Contributes to the Development of Definitive Hematopoiesis in the Fetal Liver.

Ueda T, Yokota T, Okuzaki D, Uno Y, Mashimo T, Kubota Y, Sudo T, Ishibashi T, Shingai Y, Doi Y, Ozawa T, Nakai R, Tanimura A, Ichii M, Ezoe S, Shibayama H, Oritani K, Kanakura Y.

Stem Cell Reports. 2019 Dec 10;13(6):992-1005. doi: 10.1016/j.stemcr.2019.11.002.

9.

Knock-in mice bearing constitutively active αIIb(R990W) mutation develop macrothrombocytopenia with severe platelet dysfunction.

Akuta K, Kiyomizu K, Kashiwagi H, Kunishima S, Nishiura N, Banno F, Kokame K, Kato H, Kanakura Y, Miyata T, Tomiyama Y.

J Thromb Haemost. 2020 Feb;18(2):497-509. doi: 10.1111/jth.14678. Epub 2019 Dec 6.

PMID:
31691484
10.

Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation.

Kusakabe S, Fukushima K, Maeda T, Motooka D, Nakamura S, Fujita J, Yokota T, Shibayama H, Oritani K, Kanakura Y.

Br J Haematol. 2020 Feb;188(3):438-449. doi: 10.1111/bjh.16205. Epub 2019 Sep 30.

PMID:
31566729
11.

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt).

Nagafuji K, Matsumura I, Shimose T, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Kadowaki N, Ishikawa J, Imamura Y, Yamazaki H, Akashi K, Kanakura Y.

Int J Hematol. 2019 Dec;110(6):675-682. doi: 10.1007/s12185-019-02736-5. Epub 2019 Sep 19.

PMID:
31538327
12.

Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation.

Höchsmann B, Murakami Y, Osato M, Knaus A, Kawamoto M, Inoue N, Hirata T, Murata S, Anliker M, Eggermann T, Jäger M, Floettmann R, Höllein A, Murase S, Ueda Y, Nishimura JI, Kanakura Y, Kohara N, Schrezenmeier H, Krawitz PM, Kinoshita T.

J Clin Invest. 2019 Dec 2;129(12):5123-5136. doi: 10.1172/JCI123501.

13.

Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria.

Sakurai M, Jang JH, Chou WC, Kim JS, Wilson A, Nishimura JI, Chiou TJ, Kanakura Y, Lee JW, Okamoto S.

Int J Hematol. 2019 Oct;110(4):411-418. doi: 10.1007/s12185-019-02699-7. Epub 2019 Jul 5.

PMID:
31278635
14.

Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma.

Tatsumi M, Isohashi K, Matsunaga K, Watabe T, Kato H, Kanakura Y, Hatazawa J.

Int J Clin Oncol. 2019 Oct;24(10):1292-1300. doi: 10.1007/s10147-019-01482-2. Epub 2019 Jun 5.

PMID:
31165310
15.

Noninvasive assessment of corneal alterations associated with monoclonal gammopathy.

Ichii M, Koh S, Maeno S, Busch C, Oie Y, Maeda T, Shibayama H, Nishida K, Kanakura Y.

Int J Hematol. 2019 Oct;110(4):500-505. doi: 10.1007/s12185-019-02664-4. Epub 2019 May 20.

PMID:
31111396
16.

Excessive Reactive Iron Impairs Hematopoiesis by Affecting Both Immature Hematopoietic Cells and Stromal Cells.

Tanaka H, Espinoza JL, Fujiwara R, Rai S, Morita Y, Ashida T, Kanakura Y, Matsumura I.

Cells. 2019 Mar 8;8(3). pii: E226. doi: 10.3390/cells8030226.

17.

A fatal case of Exophiala dermatitidis disseminated infection in an allogenic hematopoietic stem cell transplant recipient during micafungin therapy.

Hagiya H, Maeda T, Kusakabe S, Kawasaki K, Hori Y, Kimura K, Ueda A, Yoshioka N, Sunada A, Nishi I, Morii E, Kanakura Y, Tomono K.

J Infect Chemother. 2019 Jun;25(6):463-466. doi: 10.1016/j.jiac.2018.12.009. Epub 2019 Jan 22.

PMID:
30679025
18.

Prominent regression of corneal crystalline deposits in multiple myeloma after treatment with proteasome inhibitor.

Maeno S, Koh S, Ichii M, Oie Y, Nishida K, Kanakura Y.

Ann Hematol. 2019 Mar;98(3):793-795. doi: 10.1007/s00277-019-03614-0. Epub 2019 Jan 15. No abstract available.

PMID:
30645676
19.

In vivo confocal microscopy of multiple myeloma associated crystalline keratopathy.

Busch C, Koh S, Oie Y, Ichii M, Kanakura Y, Nishida K.

Am J Hematol. 2019 Jan;94(1):164. doi: 10.1002/ajh.25135. Epub 2018 Jul 23. No abstract available.

20.

Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation.

Ueda T, Maeda T, Kusakabe S, Fujita J, Fukushima K, Yokota T, Shibayama H, Tomiyama Y, Kanakura Y.

Int J Hematol. 2019 Feb;109(2):197-205. doi: 10.1007/s12185-018-2562-8. Epub 2018 Nov 17.

PMID:
30448938
21.

A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.

Akuta K, Kashiwagi H, Yujiri T, Nishiura N, Morikawa Y, Kato H, Honda S, Kanakura Y, Tomiyama Y.

J Thromb Haemost. 2019 Jan;17(1):206-219. doi: 10.1111/jth.14323. Epub 2018 Nov 29.

PMID:
30388316
22.

A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia.

Kanakura Y, Shirasugi Y, Yamaguchi H, Koike M, Chou T, Okamoto S, Achenbach H, Wu J, Nakaseko C.

Int J Hematol. 2018 Nov;108(5):491-498. doi: 10.1007/s12185-018-2510-7. Epub 2018 Aug 18.

PMID:
30121892
23.

Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure.

Hosokawa K, Sugimori C, Ishiyama K, Takamatsu H, Noji H, Shichishima T, Obara N, Chiba S, Ninomiya H, Shirasugi Y, Nakamura Y, Ando K, Ueda Y, Yonemura Y, Kawaguchi T, Nishimura JI, Kanakura Y, Nakao S.

Ann Hematol. 2018 Dec;97(12):2289-2297. doi: 10.1007/s00277-018-3443-1. Epub 2018 Jul 24.

PMID:
30039297
24.

Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry.

Nakaya A, Yagi H, Kaneko H, Kosugi S, Kida T, Adachi Y, Shibayama H, Kohara T, Kamitsuji Y, Fuchida SI, Uoshima N, Kawata E, Uchiyama H, Shimura Y, Takahashi T, Urase F, Ohta K, Hamada T, Miyamoto K, Kobayashi M, Shindo M, Tanaka H, Shimazaki C, Hino M, Kuroda J, Kanakura Y, Takaoari-Kondo A, Nomura S, Matsumura I; Kansai Myeloma Forum Investigators.

Leuk Res Rep. 2018 Jul 4;10:7-10. doi: 10.1016/j.lrr.2018.07.001. eCollection 2018.

25.

Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan.

Ueda Y, Obara N, Yonemura Y, Noji H, Masuko M, Seki Y, Wada K, Matsuda T, Akiyama H, Ikezoe T, Chiba S, Kanda Y, Kawaguchi T, Shichishima T, Nakakuma H, Okamoto S, Nishimura JI, Kanakura Y, Ninomiya H.

Int J Hematol. 2018 Aug;108(2):233-235. doi: 10.1007/s12185-018-2486-3.

PMID:
29980910
26.

Variable SATB1 Levels Regulate Hematopoietic Stem Cell Heterogeneity with Distinct Lineage Fate.

Doi Y, Yokota T, Satoh Y, Okuzaki D, Tokunaga M, Ishibashi T, Sudo T, Ueda T, Shingai Y, Ichii M, Tanimura A, Ezoe S, Shibayama H, Kohwi-Shigematsu T, Takeda J, Oritani K, Kanakura Y.

Cell Rep. 2018 Jun 12;23(11):3223-3235. doi: 10.1016/j.celrep.2018.05.042.

27.

Persistent methicillin-resistant Staphylococcus aureus bacteremia owing to placental abscess.

Maeda N, Hagiya H, Takiuchi T, Kusakabe S, Maeda T, Kimura K, Iwai S, Kawasaki K, Hori Y, Morii E, Kanakura Y, Kimura T, Tomono K.

J Infect Chemother. 2018 Dec;24(12):975-979. doi: 10.1016/j.jiac.2018.05.001. Epub 2018 May 24.

PMID:
29804839
28.

A case report of granulomatous amoebic encephalitis by Group 1 Acanthamoeba genotype T18 diagnosed by the combination of morphological examination and genetic analysis.

Matsui T, Maeda T, Kusakabe S, Arita H, Yagita K, Morii E, Kanakura Y.

Diagn Pathol. 2018 May 10;13(1):27. doi: 10.1186/s13000-018-0706-z.

29.

Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan.

Ueda Y, Obara N, Yonemura Y, Noji H, Masuko M, Seki Y, Wada K, Matsuda T, Akiyama H, Ikezoe T, Chiba S, Kanda Y, Kawaguchi T, Shichishima T, Nakakuma H, Okamoto S, Nishimura JI, Kanakura Y, Ninomiya H.

Int J Hematol. 2018 Jun;107(6):656-665. doi: 10.1007/s12185-018-2409-3. Epub 2018 Jan 30. Erratum in: Int J Hematol. 2018 Aug;108(2):233-235.

PMID:
29383624
30.

Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum.

Matsumura-Kimoto Y, Kuroda J, Kaneko H, Kamitsuji Y, Fuchida SI, Nakaya A, Shibayama H, Uoshima N, Yokota I, Uchiyama H, Yagi H, Kosugi S, Matsui T, Ishikawa J, Matsuda M, Ohta K, Iida M, Tanaka H, Kobayashi M, Wada K, Shimazaki C, Nomura S, Imada K, Hino M, Matsumura I, Kanakura Y, Takaori-Kondo A; Kansai Myeloma Forum Investigators.

Int J Hematol. 2018 May;107(5):541-550. doi: 10.1007/s12185-018-2416-4. Epub 2018 Jan 29.

PMID:
29380179
31.

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial).

Ishikawa J, Matsumura I, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Matsuoka KI, Shibayama H, Hino M, Hirase C, Kamimura T, Shimose T, Akashi K, Kanakura Y.

Int J Hematol. 2018 May;107(5):535-540. doi: 10.1007/s12185-018-2401-y. Epub 2018 Jan 23.

PMID:
29362980
32.

Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca2+ mobilization and ERK phosphorylation in healthy Japanese subjects.

Morikawa Y, Kato H, Kashiwagi H, Nishiura N, Akuta K, Honda S, Kanakura Y, Tomiyama Y.

Thromb Res. 2018 Feb;162:44-52. doi: 10.1016/j.thromres.2017.12.014. Epub 2017 Dec 24.

PMID:
29289806
33.

Identification of MS4A3 as a reliable marker for early myeloid differentiation in human hematopoiesis.

Ishibashi T, Yokota T, Satoh Y, Ichii M, Sudo T, Doi Y, Ueda T, Nagate Y, Hamanaka Y, Tanimura A, Ezoe S, Shibayama H, Oritani K, Kanakura Y.

Biochem Biophys Res Commun. 2018 Jan 15;495(3):2338-2343. doi: 10.1016/j.bbrc.2017.12.117. Epub 2017 Dec 22.

PMID:
29274779
34.

Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation.

Sakuragi M, Hayashi S, Maruyama M, Kiyokawa T, Nagamine K, Fujita J, Maeda T, Kato H, Kashiwagi H, Kanakura Y, Tomiyama Y.

Int J Hematol. 2018 Mar;107(3):320-326. doi: 10.1007/s12185-017-2344-8. Epub 2017 Oct 12.

PMID:
29027117
35.

A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).

Kobayashi T, Nannya Y, Ichikawa M, Oritani K, Kanakura Y, Tomita A, Kiyoi H, Kobune M, Kato J, Kawabata H, Shindo M, Torimoto Y, Yonemura Y, Hanaoka N, Nakakuma H, Hasegawa D, Manabe A, Fujishima N, Fujii N, Tanimoto M, Morita Y, Matsuda A, Fujieda A, Katayama N, Ohashi H, Nagai H, Terada Y, Hino M, Sato K, Obara N, Chiba S, Usuki K, Ohta M, Imataki O, Uemura M, Takaku T, Komatsu N, Kitanaka A, Shimoda K, Watanabe K, Tohyama K, Takaori-Kondo A, Harigae H, Arai S, Miyazaki Y, Ozawa K, Kurokawa M; for National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Am J Hematol. 2017 Dec;92(12):1324-1332. doi: 10.1002/ajh.24905. Epub 2017 Sep 28.

36.

Molecular targeting of inosine-5'-monophosphate dehydrogenase by FF-10501 promotes erythropoiesis via ROS/MAPK pathway.

Ichii M, Oritani K, Murase M, Komatsu K, Yamazaki M, Kyoden R, Kito N, Nozaki Y, Saito M, Iwamura H, Kanakura Y.

Leuk Lymphoma. 2018 Feb;59(2):448-459. doi: 10.1080/10428194.2017.1339878. Epub 2017 Jul 21.

PMID:
28730859
37.

Increased corneal densitometry as a subclinical corneal change associated with multiple myeloma.

Busch C, Koh S, Oie Y, Ichii M, Kanakura Y, Nishida K.

Eye (Lond). 2017 Dec;31(12):1745-1746. doi: 10.1038/eye.2017.132. Epub 2017 Jul 14. No abstract available.

38.

Autoimmune bullous disease and Hashimoto's disease complicated by acquired hemophilia A.

Nishiura N, Ujimoto D, Fujita J, Maeda T, Nakagawa Y, Kashiwagi H, Oritani K, Tomiyama Y, Kanakura Y.

Rinsho Ketsueki. 2017;58(3):233-238. doi: 10.11406/rinketsu.58.233. Review. Japanese.

PMID:
28381691
39.

Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88L265P mutation.

Kida T, Tanimura A, Ono A, Matsui T, Honma K, Fujita J, Maeda T, Shibayama H, Oritani K, Morii E, Kanakura Y.

Rinsho Ketsueki. 2017;58(2):155-160. doi: 10.11406/rinketsu.58.155. Japanese.

PMID:
28321094
40.

In vivo confocal microscopy of multiple myeloma associated crystalline keratopathy.

Busch C, Koh S, Oie Y, Ichii M, Kanakura Y, Nishida K.

Am J Hematol. 2017 Jun;92(6):593-594. doi: 10.1002/ajh.24692. Epub 2017 Mar 20. No abstract available. Erratum in: Am J Hematol. 2019 Jan;94(1):164.

41.

Long-term follow-up results of a phase I/II study of melphalan, prednisolone and bortezomib in Japanese transplant-ineligible multiple myeloma patients (JPN-102).

Ogiya D, Shibayama H, Nakatani E, Ando K, Suzuki K, Kuroda Y, Uchida T, Maruyama D, Matsumoto M, Matsue K, Iida S, Terui Y, Ri M, Chou T, Aotsuka N, Tabata S, Konishi J, Ohashi K, Shinagawa A, Sugiura I, Kuroda J, Miyamoto T, Ogura M, Tobinai K, Kanakura Y, Hotta T.

Rinsho Ketsueki. 2016;57(11):2311-2318. Japanese.

PMID:
27941278
42.

Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan.

Ninomiya H, Obara N, Chiba S, Usuki K, Nishiwaki K, Matsumura I, Shichishima T, Okamoto S, Nishimura JI, Ohyashiki K, Nakao S, Ando K, Kanda Y, Kawaguchi T, Nakakuma H, Harada D, Akiyama H, Kinoshita T, Ozawa K, Omine M, Kanakura Y.

Int J Hematol. 2016 Nov;104(5):548-558. Epub 2016 Jul 27.

PMID:
27464489
43.

Human CalDAG-GEFI deficiency increases bleeding and delays αIIbβ3 activation.

Kato H, Nakazawa Y, Kurokawa Y, Kashiwagi H, Morikawa Y, Morita D, Banno F, Honda S, Kanakura Y, Tomiyama Y.

Blood. 2016 Dec 8;128(23):2729-2733. Epub 2016 Sep 23.

PMID:
27663674
44.

Second primary malignancies among patients with myeloma-related-diseases in the KMF database.

Kosugi S, Shibayama H, Nakatani E, Kida T, Ohta K, Kaneko H, Yagi H, Tanaka H, Fuchida S, Nakaya A, Kobayashi M, Kuroda J, Kamitsuji Y, Uoshima N, Adachi Y, Tsudo M, Shimazaki C, Nomura S, Hino M, Matsumura I, Taniwaki M, Kanakura Y, Takaori-Kondo A.

Rinsho Ketsueki. 2016 Jul;57(7):839-47. doi: 10.11406/rinketsu.57.839. Japanese.

PMID:
27498726
45.

Prognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/Cotswolds Meeting Criteria.

Isohashi K, Tatsumi M, Kato H, Fukushima K, Maeda T, Watabe T, Shimosegawa E, Kanakura Y, Hatazawa J.

Asia Ocean J Nucl Med Biol. 2015 Summer;3(2):91-8.

46.

Pleuroparenchymal fibroelastosis after allogenic hematopoietic stem cell transplantation: important histological component of late-onset noninfectious pulmonary complication accompanied with recurrent pneumothorax.

Matsui T, Maeda T, Kida T, Fujita J, Tsuji H, Morii E, Kanakura Y.

Int J Hematol. 2016 Oct;104(4):525-30. doi: 10.1007/s12185-016-2038-7. Epub 2016 Jun 16.

PMID:
27312041
47.

Validation of a rapid one-step high sensitivity real-time quantitative PCR system for detecting major BCR-ABL1 mRNA on an International Scale.

Yoshida C, Nakamae H, Fletcher L, Koga D, Sogabe T, Matsumura I, Kanakura Y, Branford S, Naoe T.

Springerplus. 2016 May 10;5:569. doi: 10.1186/s40064-016-2258-6. eCollection 2016.

48.

New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion.

Shimomura Y, Mitsui H, Yamashita Y, Kamae T, Kanai A, Matsui H, Ishibashi T, Tanimura A, Shibayama H, Oritani K, Kuyama J, Kanakura Y.

Cancer Sci. 2016 Aug;107(8):1165-8. doi: 10.1111/cas.12970.

49.

Endothelial Cell-Selective Adhesion Molecule Expression in Hematopoietic Stem/Progenitor Cells Is Essential for Erythropoiesis Recovery after Bone Marrow Injury.

Sudo T, Yokota T, Okuzaki D, Ueda T, Ichii M, Ishibashi T, Isono T, Habuchi Y, Oritani K, Kanakura Y.

PLoS One. 2016 Apr 25;11(4):e0154189. doi: 10.1371/journal.pone.0154189. eCollection 2016.

50.

Genetic abnormalities associated with acute lymphoblastic leukemia.

Yokota T, Kanakura Y.

Cancer Sci. 2016 Jun;107(6):721-5. doi: 10.1111/cas.12927. Epub 2016 Apr 27. Review.

Supplemental Content

Loading ...
Support Center